| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K13185470 |
| PharmacoGx | BRD-K13185470 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HOXD9 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | RECQL4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | VIM | CTRPv2 | pan-cancer | AAC | -0.22 | 0.01 |
| mRNA | PGLYRP2 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | LAMA5 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | BPY2C | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | C17orf74 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | MICAL3 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | TMC2 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | PRB3 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
